Although this finding agrees with most of the studies assessing the H19/ miR-675 in BC patients, a striking finding was found where opposite levels were reported with an increase in H19 accompanied by a decrease in miRNA-675 in the HER2-positive BC subgroup [15]. Here, H19 is linked to breast cancer.